Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 163Sarcoma 48Dermatologic 9Thoracic 7Breast 6Lymphoid 2Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 9Pancreatic Neoplasms 6Ovarian Neoplasms 5Sarcoma 4Neuroblastoma 4Liver Neoplasms 4Wilms Tumor 3Somatostatinoma 3Rectal Neoplasms 3Osteosarcoma 3Neuroendocrine Tumors 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Medulloblastoma 3Gastrointestinal Stromal Tumors 3Esophageal Neoplasms 3Astrocytoma 3Zollinger-Ellison Syndrome 2Vipoma 2Testicular Neoplasms 2Teratoma 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Pheochromocytoma 2Ovarian Germ Cell Cancer 2Optic Nerve Glioma 2Oligodendroglioma 2Neoplasm Metastasis 2Melanoma 2

Interventions

Magnetic Resonance Spectroscopy 7Radiotherapy 6Radiosurgery 4pembrolizumab 3Specimen Handling 3Paclitaxel 3Fluorodeoxyglucose F18 3Carboplatin 3sargramostim 2cediranib 2Thiotepa 2Radiation 2Nivolumab 2Melphalan 2IFL protocol 2Granulocyte Colony-Stimulating Factor 2Genetic Testing 2Gemcitabine 2FAPI-46 2Busulfan 2130-nm albumin-bound paclitaxel 2tipifarnib 1sodium thiosulfate 1regorafenib 1paclitaxel-Angiopep-2 conjugate 1montelukast 1etoposide phosphate 1entrectinib 1entinostat 1clevudine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Temozolomide × Gastrointestinal × Clear all
NCT07492680 2026-03-25

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Bristol-Myers Squibb

Phase 2 Not yet recruiting
260 enrolled
CNSDermatologicGastrointestinal

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡